InsiderTrades.com logo

COCP Insider Trading

Insider Ownership Percentage: 28.14%
Insider Buying (Last 12 Months): $22,760.00
Insider Selling (Last 12 Months): $0.00

Cocrystal Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Cocrystal Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cocrystal Pharma Share Price & Price History

Current Price: $1.04
Price Change: ▼ Price Decrease of -0.005 (-0.48%)
As of 12/4/2025 04:55 PM ET

This chart shows the closing price history over time for COCP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Cocrystal Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/26/2025Phillip Md Et Al FrostDirectorBuy4,000$0.99$3,960.001,703,551View SEC Filing Icon  
11/25/2025Phillip Md Et Al FrostDirectorBuy20,000$0.94$18,800.001,699,551View SEC Filing Icon  
4/4/2023Phillip Md Et Al FrostDirectorBuy1,015,229$1.97$2,000,001.131,319,838View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Cocrystal Pharma (NASDAQ:COCP)

6.72% of Cocrystal Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at COCP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Cocrystal Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/6/2023Parallel Advisors LLC15,228$30K0.0%-91.7%0.188%Search for SEC Filing on Google Icon
1/20/2022Parallel Advisors LLC182,708$0.12M0.0%-50.3%0.187%Search for SEC Filing on Google Icon
11/15/2021Mariner LLC300,055$0.32M0.0%+50.0%0.308%Search for SEC Filing on Google Icon
11/15/2021HighTower Advisors LLC63,001$66K0.0%-30.8%0.065%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC2,026,766$2.13M0.0%-21.9%2.079%Search for SEC Filing on Google Icon
11/9/2021Barclays PLC26,665$28K0.0%+248.5%0.027%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.1,113,765$1.17M0.0%-2.1%1.143%Search for SEC Filing on Google Icon
11/2/2021Raymond James Financial Services Advisors Inc.24,243$25K0.0%+108.7%0.025%Search for SEC Filing on Google Icon
8/16/2021State Street Corp274,427$0.34M0.0%N/A0.282%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.138,168$0.17M0.0%+62.1%0.142%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Cocrystal Pharma logo
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.
Read More on Cocrystal Pharma

Today's Range

Now: $1.04
Low: $1.01
High: $1.04

50 Day Range

MA: $1.09
Low: $0.90
High: $1.26

52 Week Range

Now: $1.04
Low: $0.90
High: $3.26

Volume

48,692 shs

Average Volume

71,717 shs

Market Capitalization

$14.26 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.05

Who are the company insiders with the largest holdings of Cocrystal Pharma?

Cocrystal Pharma's top insider shareholders include:
  1. Phillip Md Et Al Frost (Director)
Learn More about top insider investors at Cocrystal Pharma.